Phase 1 Evaluation of the Bioequivalence and Drug‐Drug Interaction Potential of a Novel Fixed‐Dose Combination of Ezetimibe, Atorvastatin, and Amlodipine

Documenti analoghi

• Pharmacokinetics and Safety of a Fixed‐Dose Combination of Alogliptin and Extended‐Release Metformin Under Fasting and/or Fed Conditions in Healthy Adults
  di: Ji Hye Song, et al.
  Pubblicazione: (2025)
• Pharmacokinetic and Safety Comparison of Fixed‐Dose Combination of Cilostazol/Rosuvastatin (200 + 20 mg) Versus Concurrent Administration of the Separate Components in Healthy Adults
  di: Jae Hoon Kim, et al.
  Pubblicazione: (2024)
• Pharmacokinetics and Bioequivalence of Fixed‐Dose Combination of Simvastatin and Ezetimibe Tablets: A Randomized, Crossover, Open‐Label Study in Healthy Volunteers
  di: Chuei Wuei Leong, et al.
  Pubblicazione: (2024)
• Pharmacokinetic Interaction Among Amlodipine, Losartan, and Chlorthalidone after a Single Oral Administration in Healthy Male Subjects
  di: Seol Ju Moon, et al.
  Pubblicazione: (2026)
• Assessment of Pharmacokinetic Drug Interaction of Asciminib with Atorvastatin in Healthy Participants
  di: Matthias Hoch, et al.
  Pubblicazione: (2025)